Logistics and Supply Chain for Korea Medical Device Imports

Approval Is Not Importation

A common surprise for foreign manufacturers entering Korea: MFDS approval is not enough to clear customs. The first shipment frequently sits in bond for days while the customs broker, the KLH, and the manufacturer reconcile documents that none of them had thought about during the regulatory process. The cost of this surprise is real — perishable products lose shelf life, hospital launch dates slip, distributors take a credibility hit on their first delivery.

The supply chain layer has its own set of requirements, only loosely connected to MFDS. Three areas drive most of the surprises: import declaration paperwork, cold chain and sterile barrier integrity, and lot-level traceability for the KLH's import record.

The Import Declaration Stack

Every medical device entering Korea requires an import declaration filed by a licensed customs broker. For MFDS-regulated products, the declaration references:

The MFDS notification or approval number (issued at registration)
The KLH (Korea License Holder) as the importer of record
The Korean item code for the product
The Harmonized System (HS) code for customs duty assessment
Lot or serial numbers for the shipped units
The certificate of free sale or equivalent (for some product types)

A common error: the MFDS notification number is issued before the labeling reflects the KLH name. The first shipment carries pre-KLH labeling, and customs holds the shipment because the labeled responsible entity does not match the import declaration's KLH.

The fix is to time the first shipment so that labeling with the final KLH name is produced after the notification number issues. This is a 2–3 week sequence that has to be planned, not improvised.

Cold Chain and Sterile Barrier

Korea's medical device standards for cold chain and sterile barrier integrity reference ISO standards, but the enforcement is stricter on import than EU or US practice in two areas:

Temperature logger placement. Cold-chain shipments must include continuous-recording temperature loggers placed inside the secondary packaging, not on the outside. Customs and KLH inspection at receiving will verify the logger record. Excursions outside the validated range trigger quarantine pending KLH review.
Sterile barrier inspection at receipt. The KLH is expected to inspect sterile barrier packaging at the receiving warehouse before goods are released to distributors. The inspection record is part of the KGMP-audited quality system. A KLH that does not perform receiving inspection generates a finding at the next KGMP surveillance audit.

For implantable devices and sterile diagnostics, building the receiving-inspection procedure into the KLH agreement is critical. The default distributor logistics flow does not include receiving inspection at the KLH-controlled point.

Lot Traceability and the Import Record

KGMP requires the KLH to maintain a lot-level import record tying every Korean shipment back to the manufacturer's batch records. The record includes:

Lot or serial number
Quantity received
Date of import
Source manufacturing site
Storage location until distributor pickup
Destination distributor or hospital
Disposition (sold, returned, destroyed, expired)

The record is reviewed during KGMP surveillance audits. Common findings:

Lot numbers in the import record do not match the manufacturer's batch records.
Quantity discrepancies between import declaration and physical receipt.
Missing destination data for samples or trial units.

The fix is operational: the KLH's warehouse management system must integrate with the manufacturer's batch-record system, either through direct EDI or through structured handoff at each shipment.

Distribution Models and Their Logistics Implications

The KLH structure (covered in our KLH guide) shapes the logistics flow:

Distributor-as-KLH

The distributor's warehouse is the importer of record's receiving point. Logistics is simple: manufacturer → distributor warehouse → hospitals. The distributor's WMS holds the import record.

Risk: the manufacturer has no direct visibility into Korean inventory or lot disposition. KGMP surveillance audits are dependent on the distributor's record discipline.

Independent KLH with Single Distributor

The independent KLH typically receives goods at a separate bonded warehouse, performs inspection and the import-record logging, then transfers to the distributor's warehouse for commercial distribution.

The extra logistics step (KLH warehouse → distributor warehouse) adds 1–3 days to delivery cycles and requires the independent KLH to maintain or contract a warehouse.

Independent KLH with Multiple Distributors

This is where the independent KLH structure pays for itself logistically. The KLH warehouse is the single import point; distributors draw from KLH inventory rather than each importing independently. Multi-distributor portfolios that try to operate without a central KLH-side inventory point spend significant overhead on per-distributor import declarations.

Cold Chain: When the Plane Lands

For temperature-controlled products, the highest-risk window is between the airline cargo hand-off and the bonded warehouse receipt. This window can be 12–24 hours at Incheon, longer at regional airports. Practical controls:

Use airline cargo services with continuous cold storage from arrival to broker handoff.
Place loggers inside primary cartons (preferred) or inside secondary cartons (minimum).
Pre-arrange priority broker pickup for cold-chain shipments. Standard broker queues run 24–48 hours.
Train the KLH receiving team on logger download procedures so excursion data is reviewed within 4 hours of receipt.

A 2-hour excursion outside the validated range with no documented investigation is enough to trigger a KGMP audit finding the next surveillance cycle.

Sterilization Validation: Tied to Site, Not SKU

Korean MFDS treats sterilization validation as a manufacturing-site attribute. If the manufacturer changes sterilization contractor or moves the sterilization step to a new facility, this is a material change requiring notification. The supply chain implication: locking in sterilization contractors before submission, and treating sterilization-contractor changes as Korea-specific decisions even if they appear straightforward in global supply chain planning.

A Working Supply Chain Architecture

Manufacturers running clean Korean supply chains share a common structure:

Manufacturer (overseas)
   │
   │ shipment with lot data + cold chain logger
   ▼
Customs broker → bonded clearance
   │
   ▼
KLH receiving warehouse (sterile inspection + logger review + import record)
   │
   │ released inventory
   ▼
Distributor warehouse(s)
   │
   ▼
Hospitals / clinical end users

Each arrow has a documented procedure, an SLA, and a record that the KGMP auditor can sample.

Three Recommendations

Recommendation 1: Pilot the first shipment. Send a small pilot shipment (50–100 units) 3–4 weeks before the planned commercial launch. Walk through customs, KLH receipt, distributor transfer with actual goods. The exercise will surface 3–5 minor procedural gaps that are cheap to fix at pilot but expensive at full commercial scale.

Recommendation 2: Integrate the import record into the manufacturer's batch system. Treat the Korean import record as an extension of the manufacturer's batch traceability, not as a separate KLH-side system. The integration cost is low; the audit-defensibility benefit is high.

Recommendation 3: Plan distributor switches with logistics in mind. Distributor switches that ignore the logistics layer (warehouse contracts, inspection procedures, broker relationships) frequently miss the first month of revenue under the new distributor. Logistics transition should run 30 days ahead of commercial transition.

Where Leanabl Plugs In

Our Logistics service designs the Korean supply chain layer specifically for medical device imports — including KLH receiving inspection, cold-chain protocols, and lot-traceability integration. For manufacturers running a distributor transition with logistics implications, Seamless Distributor Transition coordinates the regulatory and supply chain switchover together.